VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASH 2022 | What to look forward to in lymphoma at ASH 2022

Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN, briefly comments on what he is looking forward to at ASH 2022, including clinical trial updates in mantle cell lymphoma (MCL), and updates on CAR-T cell therapy and bispecific antibodies. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter